In8bio Return on Equity (ROE) Growth & History (INAB)
In8bio's return on equity was −92.49% for fiscal 2025.
View full In8bio company overviewIn8bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −92.49% | +61.95 pp |
| 2024 | 2024-12-31 | −154.44% | −28.55 pp |
| 2023 | 2023-12-31 | −125.90% | — |
In8bio quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −23.24% | +11.75 pp |
| Q1 2026 | 2026-03-31 | −20.22% | +18.92 pp |
| Q4 2025 | 2025-12-31 | −24.26% | +29.15 pp |
| Q3 2025 | 2025-09-30 | −27.11% | +36.70 pp |
| Q2 2025 | 2025-06-30 | −34.99% | +20.42 pp |
| Q1 2025 | 2025-03-31 | −39.15% | +1.18 pp |
| Q4 2024 | 2024-12-31 | −53.41% | −17.82 pp |
| Q3 2024 | 2024-09-30 | −63.81% | −27.57 pp |
| Q2 2024 | 2024-06-30 | −55.41% | −15.42 pp |
| Q1 2024 | 2024-03-31 | −40.33% | −2.24 pp |
| Q4 2023 | 2023-12-31 | −35.59% | −5.77 pp |
| Q3 2023 | 2023-09-30 | −36.25% | −9.88 pp |
| Q2 2023 | 2023-06-30 | −39.99% | −15.82 pp |
| Q1 2023 | 2023-03-31 | −38.08% | — |
| Q4 2022 | 2022-12-31 | −29.82% | +211.12 pp |
| Q3 2022 | 2022-09-30 | −26.36% | +4.75 pp |
| Q2 2022 | 2022-06-30 | −24.17% | — |
| Q4 2021 | 2021-12-31 | −240.95% | — |
| Q3 2021 | 2021-09-30 | −31.11% | — |
In8bio return on equity trends
Between the periods ended 2023-12-31 and 2025-12-31, In8bio's return on equity increased from −125.90% to −92.49%, a change of +33.41 percentage points. The latest reported quarter, Q2 2026, shows −23.24%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review In8bio source filings ↗